
Europe Wound Care Market Forecast by 2033
Market Size in 2024: USD 5.8 Billion
Market Forecast in 2033: USD 8.4 Billion
Market Growth Rate 2025-2033: 4.1%
The Europe wound care market is projected to grow from USD 5.8 billion in 2024 to USD 8.4 billion by 2033, registering a CAGR of 4.1%. Rising prevalence of chronic wounds, an aging population, and continuous adoption of advanced dressings and negative-pressure devices underpin this steady expansion.
Growth Drivers Powering the Europe Wound Care Market
Diabetes Epidemic and Chronic-Wound Surge
By 2045, one in ten Europeans will live with diabetes, according to the WHO, which equals 61 million persons in danger of diabetic foot ulcers. In 2024, Germany alone reported 450,000 DFU cases, each needing an average of 12 advanced dressings per healing cycle. National norms in France and Spain now call for multidisciplinary foot-care teams that provide hydro-fiber and antibiotic dressings within 24 hours of ulcer identification. Dedicated wound-care departments are growing in hospitals as glycaemic control worsens post-COVID; this locks in ongoing demand for high-margin active dressings and NPWT consumables.
Aging Population and Pressure-Ulcer Prevention Mandates
Europeans 65+ will number 130 million by 2030; the European Pressure Ulcer Panel estimates that 2.5 million older residents develop facility-acquired pressure ulcers. Every year, England's NHS implemented a zero-tolerance policy in April 2025, under which every care-home resident had to have a Braden-scale risk assessment twice per week. Facilities not meeting objectives lose up to 2% of their public support; therefore, silicone-foam dressings and sensor-based monitoring patches are bought. In Sweden and Denmark, comparable reimbursement penalties are transforming prevention budgets into long-term supply contracts and broadening the addressable market outside of acute care to include homes and long-term care environments.
Ambulatory Surgery Boom and Post-Operative Dressing Demand
Driven by cost-containment and patient preference, day-case procedures in the EU-27 increased 34% between 2019 and 2024. Each calling sterile, waterproof dressings for at-home recovery, Germany currently discharges 68% of hernia and 72% of orthopaedic procedures on the same day. Outpatient clinics favor single-use NPWT pumps weighing less than 150 g since they let patients move around without requiring readmission. Manufacturers of portable, consumer-friendly equipment catch incremental volume that helps to balance slower inpatient admissions as hospitals adopt short-stay models.
Request a Free Sample Copy of the Report: https://www.imarcgroup.com/Europe-Wound-Care-Market/requestsample
Europe Wound Care Market Segmentation
Analysis by Product Type:
Advance Wound Care Products
Foam Dressing
Hydrocolloid Dressing
Film Dressing
Alginate Dressing
Hydrogel Dressing
Collagen Dressing
Others
Surgical Wound Care Products
Sutures
Staplers
Tissue Adhesive, Sealants and Hemostats
Anti-effective Dressing
Traditional Wound Care Products
Medical Tapes
Cleansing Agent
Active Wound Care Products
Biological Skin Substitutes
Topical Agents
Wound Therapy Devices Products
Negative Pressure Wound Therapy
Oxygen and Hyperbaric Oxygen Equipment
Electric Stimulation Devices
Pressure Relief Devices
Wound Assessment and Monitoring Devices
Others
Analysis by Wound Type:
Chronic Wounds
Diabetic Ulcers
Pressure Ulcers
Venous Leg Ulcers
Others
Acute Wounds
Surgical Traumatic Wounds
Burns
Analysis by End User:
Hospitals and Clinics
Long-Term Care Facilities
Home Care Setting
Others
Country Analysis:
Germany
France
United Kingdom
Italy
Spain
Others
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Europe Wound Care Market News
March 2025: Solventum launched a 7-day V.A.C. Peel-and-Place dressing that reduces home nursing visits by 67%, validated in German diabetic-foot pilot programs.
February 2025: Mölnlycke Health Care secured a EUR 90 million NHS supply contract for Mepilex foam dressings used in pressure-ulcer prevention across 1,200 English care homes.
January 2025: Researchers at Lund University published positive six-month results for a bioelectric bandage that accelerates venous-leg-ulcer healing by 28% compared with standard care.
December 2024: The European Commission approved EUR 45 million in Horizon-Europe funding to develop AI-driven wound-imaging tools for remote monitoring in rural regions.
Key highlights of the Report:
Market Performance (2019-2024)
Market Outlook (2025-2033)
COVID-19 Impact on the Market
Porter’s Five Forces Analysis
Strategic Recommendations
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Structure of the Market
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Write a comment ...